Modulation of Alzheimer’s disease brain pathology in mice by gut bacterial depletion: the role of IL-17a

References

• Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, Carlsson CM, Asthana S, Zetterberg H, Blennow K. et al. Gut microbiome alterations in Alzheimer’s disease. Sci Rep. 2017;7(1):13537. doi:10.1038/s41598-017-13601-y.
   PubMed Web of Science ®Google Scholar
• Dunham SJB, McNair KA, Adams ED, Avelar-Barragan J, Forner S, Mapstone M, Whiteson KL, Huffnagle GB. Longitudinal analysis of the microbiome and metabolome in the 5xfAD Mouse Model of Alzheimer’s Disease. mBio. 2022;13(6):e0179422. doi:10.1128/mbio.01794-22.
   PubMed Web of Science ®Google Scholar
• Meyer K, Lulla A, Debroy K, Shikany JM, Yaffe K, Meirelles O, Launer LJ. Association of the gut microbiota with cognitive function in midlife. JAMA Netw Open. 2022;5(2):e2143941. doi:10.1001/jamanetworkopen.2021.43941.
   PubMed Web of Science ®Google Scholar
• Zhang T, Gao G, Kwok LY, Sun Z. Gut microbiome-targeted therapies for Alzheimer’s disease. Gut Microbes. 2023;15(2):2271613. doi:10.1080/19490976.2023.2271613.
   PubMed Web of Science ®Google Scholar
• Ma C, Li Y, Mei Z, Yuan C, Kang JH, Grodstein F, Ascherio A, Willett WC, Chan AT, Huttenhower C. et al. Association between bowel movement pattern and cognitive function: Prospective cohort study and a metagenomic analysis of the gut microbiome. Neurology. 2023;101(20):e2014–27. doi:10.1212/WNL.0000000000207849.
   PubMed Web of Science ®Google Scholar
• Grabrucker S, Marizzoni M, Silajdzic E, Lopizzo N, Mombelli E, Nicolas S, Dohm-Hansen S, Scassellati C, Moretti DV, Rosa M. et al. Microbiota from Alzheimer’s patients induce deficits in cognition and hippocampal neurogenesis. Brain. 2023;146(12):4916–4934. doi:10.1093/brain/awad303.
   PubMed Web of Science ®Google Scholar
• Dodiya HB, Kuntz T, Shaik SM, Baufeld C, Leibowitz J, Zhang X, Gottel N, Zhang X, Butovsky O, Gilbert JA. et al. Sex-specific effects of microbiome perturbations on cerebral Abeta amyloidosis and microglia phenotypes. J Exp Med. 2019;216(7):1542–1560. doi:10.1084/jem.20182386.
   PubMed Web of Science ®Google Scholar
• Harach T, Marungruang N, Duthilleul N, Cheatham V, Mc Coy KD, Frisoni G, Neher JJ, Fak F, Jucker M, Lasser T. et al. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep. 2017;7(1):41802. doi:10.1038/srep41802.
   PubMedGoogle Scholar
• Kaur H, Nookala S, Singh S, Mukundan S, Nagamoto-Combs K, Combs CK. Sex-dependent effects of intestinal microbiome manipulation in a mouse model of alzheimer’s disease. Cells. 2021;10(9):2370. doi:10.3390/cells10092370.
   PubMed Web of Science ®Google Scholar
• Minter MR, Hinterleitner R, Meisel M, Zhang C, Leone V, Zhang X, Oyler-Castrillo P, Zhang X, Musch MW, Shen X. et al. Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1DeltaE9 murine model of Alzheimer’s disease. Sci Rep. 2017;7(1):10411. doi:10.1038/s41598-017-11047-w.
   PubMed Web of Science ®Google Scholar
• Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, Musch MW, Liao F, Ward JF, Holtzman DM. et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease. Sci Rep. 2016;6(1):30028. doi:10.1038/srep30028.
   PubMed Web of Science ®Google Scholar
• Liu P, Wu L, Peng G, Han Y, Tang R, Ge J, Zhang L, Jia L, Yue S, Zhou K. et al. Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav Immun. 2019;80:633–643. doi:10.1016/j.bbi.2019.05.008.
   PubMed Web of Science ®Google Scholar
• Murray ER, Kemp M, Nguyen TT. The microbiota-gut-brain axis in alzheimer’s disease: A review of taxonomic alterations and potential avenues for Interventions. Arch Clin Neuropsychol. 2022;37(3):595–607. doi:10.1093/arclin/acac008.
   PubMed Web of Science ®Google Scholar
• Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C. et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60–68. doi:10.1016/j.neurobiolaging.2016.08.019.
   PubMed Web of Science ®Google Scholar
• Vital M, Karch A, Pieper DH, Shade A. Colonic Butyrate-Producing Communities in Humans: an overview using omics data. mSystems. 2017;2(6). doi:10.1128/mSystems.00130-17.
   PubMed Web of Science ®Google Scholar
• Erny D, Dokalis N, Mezo C, Castoldi A, Mossad O, Staszewski O, Frosch M, Villa M, Fuchs V, Mayer A. et al. Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. Cell Metab. 2021;33(11):2260–2276 e2267. doi:10.1016/j.cmet.2021.10.010.
   PubMed Web of Science ®Google Scholar
• Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18(7):965–977. doi:10.1038/nn.4030.
   PubMed Web of Science ®Google Scholar
• Colombo AV, Sadler RK, Llovera G, Singh V, Roth S, Heindl S, Sebastian Monasor L, Verhoeven A, Peters F, Parhizkar S. et al. Microbiota-derived short chain fatty acids modulate microglia and promote Abeta plaque deposition. Elife. 2021;10:e59826. doi:10.7554/eLife.59826.
   PubMed Web of Science ®Google Scholar
• Xie J, Bruggeman A, De Nolf C, Vandendriessche C, Van Imschoot G, Van Wonterghem E, Vereecke L, Vandenbroucke RE. Gut microbiota regulates blood-cerebrospinal fluid barrier function and Abeta pathology. Embo J. 2023;42(17):e111515. doi:10.15252/embj.2022111515.
   PubMed Web of Science ®Google Scholar
• Quan W, Luo Q, Hao W, Tomic I, Furihata T, Schulz-Schaffer W, Menger MD, Fassbender K, Liu Y. Haploinsufficiency of microglial MyD88 ameliorates Alzheimer’s pathology and vascular disorders in APP/PS1-transgenic mice. Glia. 2021;69(8):1987–2005. doi:10.1002/glia.24007.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Xie L, Schroder J, Schuster IS, Nakai M, Sun G, Sun YBY, Marino E, Degli-Esposti MA, Marques FZ. et al. Dietary fiber and microbiota metabolite receptors enhance cognition and alleviate disease in the 5xFAD Mouse model of alzheimer’s disease. J Neurosci. 2023;43(37):6460–6475. doi:10.1523/JNEUROSCI.0724-23.2023.
   PubMed Web of Science ®Google Scholar
• Dupraz L, Magniez A, Rolhion N, Richard ML, Da Costa G, Touch S, Mayeur C, Planchais J, Agus A, Danne C. et al. Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal γδ T cells. Cell Rep. 2021;36(1):109332. doi:10.1016/j.celrep.2021.109332.
   PubMed Web of Science ®Google Scholar
• Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH. et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40(1):128–139. doi:10.1016/j.immuni.2013.12.007.
   PubMed Web of Science ®Google Scholar
• Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2011;108 Suppl 1(supplement_1):4615–4622. doi:10.1073/pnas.1000082107.
   PubMedGoogle Scholar
• Benakis C, Brea D, Caballero S, Faraco G, Moore J, Murphy M, Sita G, Racchumi G, Ling L, Pamer EG. et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat Med. 2016;22(5):516–523. doi:10.1038/nm.4068.
   PubMed Web of Science ®Google Scholar
• Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif AM, Spinrad A, Tsitsou-Kampeli A, Sarel A, Cahalon L, Schwartz M. Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer’s disease pathology. Nat Commun. 2015;6(1):7967. doi:10.1038/ncomms8967.
   PubMedGoogle Scholar
• Dansokho C, Ait Ahmed D, Aid S, Toly-Ndour C, Chaigneau T, Calle V, Cagnard N, Holzenberger M, Piaggio E, Aucouturier P. et al. Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain. 2016;139(Pt 4):1237–1251. doi:10.1093/brain/awv408.
   PubMed Web of Science ®Google Scholar
• Luo Q, Schnoder L, Hao W, Litzenburger K, Decker Y, Tomic I, Menger MD, Liu Y, Fassbender K. p38alpha-MAPK-deficient myeloid cells ameliorate symptoms and pathology of APP-transgenic Alzheimer’s disease mice. Aging Cell. 2022;21(8):e13679. doi:10.1111/acel.13679.
   PubMed Web of Science ®Google Scholar
• Marizzoni M, Mirabelli P, Mombelli E, Coppola L, Festari C, Lopizzo N, Luongo D, Mazzelli M, Naviglio D, Blouin JL. et al. A peripheral signature of Alzheimer’s disease featuring microbiota-gut-brain axis markers. Alzheimers Res Ther. 2023;15(1):101. doi:10.1186/s13195-023-01218-5.
   PubMed Web of Science ®Google Scholar
• Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, Nguyen M, Haditsch U, Raha D, Griffin C. et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5(1):eaau3333. doi:10.1126/sciadv.aau3333.
   PubMed Web of Science ®Google Scholar
• Fassbender K, Walter S, Kuhl S, Landmann R, Ishii K, Bertsch T, Stalder AK, Muehlhauser F, Liu Y, Ulmer AJ. et al. The LPS receptor (CD14) links innate immunity with Alzheimer’s disease. FASEB J. 2004;18(1):203–205. doi:10.1096/fj.03-0364fje.
   PubMed Web of Science ®Google Scholar
• Liu S, Liu Y, Hao W, Wolf L, Kiliaan AJ, Penke B, Rube CE, Walter J, Heneka MT, Hartmann T. et al. TLR2 is a primary receptor for Alzheimer’s amyloid beta peptide to trigger neuroinflammatory activation. J Immunol. 2012;188(3):1098–1107. doi:10.4049/jimmunol.1101121.
   PubMed Web of Science ®Google Scholar
• Liu Y, Walter S, Stagi M, Cherny D, Letiembre M, Schulz-Schaeffer W, Heine H, Penke B, Neumann H, Fassbender K. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer’s amyloid peptide. Brain. 2005;128(Pt 8):1778–1789. doi:10.1093/brain/awh531.
   PubMedGoogle Scholar
• O’Neill LA, Golenbock D, Bowie AG. The history of Toll-like receptors - redefining innate immunity. Nat Rev Immunol. 2013;13(6):453–460. doi:10.1038/nri3446.
   PubMed Web of Science ®Google Scholar
• Hao W, Liu Y, Liu S, Walter S, Grimm MO, Kiliaan AJ, Penke B, Hartmann T, Rube CE, Menger MD. et al. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer’s disease-related symptoms and pathology. Brain. 2011;134(Pt 1):278–292. doi:10.1093/brain/awq325.
   PubMedGoogle Scholar
• Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, Bode B, Manietta N, Walter J, Schulz-Schuffer W. et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer’s disease. Cell Physiol Biochem. 2007;20(6):947–956. doi:10.1159/000110455.
   PubMed Web of Science ®Google Scholar
• Panza F, Lozupone M, Solfrizzi V, Watling M, Imbimbo BP. Time to test antibacterial therapy in Alzheimer’s disease. Brain. 2019;142(10):2905–2929. doi:10.1093/brain/awz244.
   PubMedGoogle Scholar
• Rakusa E, Fink A, Tamguney G, Heneka MT, Doblhammer G. Sporadic use of antibiotics in older adults and the risk of dementia: a nested case-control study based on German health claims data. J Alzheimers Dis. 2023;93(4):1329–1339. doi:10.3233/JAD-221153.
   PubMed Web of Science ®Google Scholar
• Drummond RA, Desai JV, Ricotta EE, Swamydas M, Deming C, Conlan S, Quinones M, Matei-Rascu V, Sherif L, Lecky D. et al. Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria. Cell Host Microbe. 2022;30(7):1020–1033 e1026. doi:10.1016/j.chom.2022.04.013.
   PubMed Web of Science ®Google Scholar
• Nebel RA, Aggarwal NT, Barnes LL, Gallagher A, Goldstein JM, Kantarci K, Mallampalli MP, Mormino EC, Scott L, Yu WH. et al. Understanding the impact of sex and gender in Alzheimer’s disease: A call to action. Alzheimers Dement. 2018;14(9):1171–1183. doi:10.1016/j.jalz.2018.04.008.
   PubMed Web of Science ®Google Scholar
• Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, Jaggi F, Wolburg H, Gengler S. et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 2006;7(9):940–946. doi:10.1038/sj.embor.7400784.
   PubMed Web of Science ®Google Scholar
• Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 2002;17(3):375–387. doi:10.1016/S1074-7613(02)00391-6.
   PubMed Web of Science ®Google Scholar
• Esplugues E, Huber S, Gagliani N, Hauser AE, Town T, Wan YY, O’Connor W Jr., Rongvaux A, Van Rooijen N, Haberman AM. et al. Control of TH17 cells occurs in the small intestine. Nature. 2011;475(7357):514–518. doi:10.1038/nature10228.
   PubMed Web of Science ®Google Scholar
• Liu S, da Cunha AP, Rezende RM, Cialic R, Wei Z, Bry L, Comstock LE, Gandhi R, Weiner HL. The host shapes the gut microbiota via fecal MicroRNA. Cell Host Microbe. 2016;19(1):32–43. doi:10.1016/j.chom.2015.12.005.
   PubMed Web of Science ®Google Scholar
• Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, Kd M. et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141(2):599–609, 609 e591–593. doi:10.1053/j.gastro.2011.04.052.
   Web of Science ®Google Scholar
• Jensen JC, Gugler R. Single- and multiple-dose metronidazole kinetics. Clin Pharmacol Ther. 1983;34(4):481–487. doi:10.1038/clpt.1983.201.
   PubMed Web of Science ®Google Scholar
• Lau SF, Wu W, Seo H, Aky F, Ip NY. Quantitative in vivo assessment of amyloid-beta phagocytic capacity in an Alzheimer’s disease mouse model. STAR Protoc. 2021;2(1):100265. doi:10.1016/j.xpro.2020.100265.
   PubMedGoogle Scholar
• Couter CJ, Surana NK. Isolation and flow cytometric characterization of murine small intestinal lymphocytes. JoVE (J Visualized Exp). 2016;111:e54114.
   Google Scholar
• Liu Y, Liu X, Hao W, Decker Y, Schomburg R, Fulop L, Pasparakis M, Menger MD, Fassbender K. IKKbeta deficiency in myeloid cells ameliorates Alzheimer’s disease-related symptoms and pathology. J Neurosci. 2014;34(39):12982–12999. doi:10.1523/JNEUROSCI.1348-14.2014.
   PubMed Web of Science ®Google Scholar
• Hao W, Decker Y, Schnoder L, Schottek A, Li D, Menger MD, Fassbender K, Liu Y. Deficiency of IkappaB kinase beta in myeloid cells reduces severity of experimental autoimmune encephalomyelitis. Am J Pathol. 2016;186(5):1245–1257. doi:10.1016/j.ajpath.2016.01.004.
   PubMed Web of Science ®Google Scholar
• Benjamin JL, Sumpter R Jr., Levine B, Hooper LV. Intestinal epithelial autophagy is essential for host defense against invasive bacteria. Cell Host Microbe. 2013;13(6):723–734. doi:10.1016/j.chom.2013.05.004.
   PubMed Web of Science ®Google Scholar
• Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010;10(7):479–489. doi:10.1038/nri2800.
   PubMed Web of Science ®Google Scholar
• Hao W, Luo Q, Menger MD, Fassbender K, Liu Y. Treatment with CD52 antibody protects neurons in experimental autoimmune encephalomyelitis mice during the recovering phase. Front Immunol. 2021;12:792465. doi:10.3389/fimmu.2021.792465.
   PubMed Web of Science ®Google Scholar
• Thapa M, Kumari A, Chin C-Y, Choby JE, Jin F, Bogati B, Chopyk DM, Koduri N, Pahnke A, Elrod EJ. et al. Translocation of gut commensal bacteria to the brain. bioRxiv. 2023;2023.08.30:555630. doi: 10.1101/2023.08.30.555630.
   Google Scholar
• Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B. et al. A unique microglia type associated with restricting development of alzheimer’s disease. Cell. 2017;169(7):1276–1290 e1217. doi:10.1016/j.cell.2017.05.018.
   PubMed Web of Science ®Google Scholar
• Roberts KF, Elbert DL, Kasten TP, Patterson BW, Sigurdson WC, Connors RE, Ovod V, Munsell LY, Mawuenyega KG, Miller-Thomas MM. et al. Amyloid-β efflux from the central nervous system into the plasma. Ann Neurol. 2014;76(6):837–844. doi:10.1002/ana.24270.
   PubMed Web of Science ®Google Scholar
• Kuhnke D, Jedlitschky G, Grube M, Krohn M, Jucker M, Mosyagin I, Cascorbi I, Walker LC, Kroemer HK, Warzok RW. et al. MDR1-P-Glycoprotein (ABCB1) mediates transport of Alzheimer’s amyloid-beta peptides–implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol. 2007;17(4):347–353. doi:10.1111/j.1750-3639.2007.00075.x.
   PubMed Web of Science ®Google Scholar
• Shinohara M, Tachibana M, Kanekiyo T, Bu G. Role of LRP1 in the pathogenesis of Alzheimer’s disease: evidence from clinical and preclinical studies. J Lipid Res. 2017;58(7):1267–1281. doi:10.1194/jlr.R075796.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang Y, Sterling K, Song W. Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential. Transl Neurodegener. 2022;11(1):4. doi:10.1186/s40035-022-00279-0.
   PubMed Web of Science ®Google Scholar
• Frohlich EE, Farzi A, Mayerhofer R, Reichmann F, Jacan A, Wagner B, Zinser E, Bordag N, Magnes C, Frohlich E. et al. Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication. Brain Behav Immun. 2016;56:140–155. doi:10.1016/j.bbi.2016.02.020.
   PubMed Web of Science ®Google Scholar
• Chandra S, Sisodia SS, Vassar RJ. The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored. Mol Neurodegener. 2023;18(1):9. doi:10.1186/s13024-023-00595-7.
   PubMed Web of Science ®Google Scholar
• Chandra S, Di Meco A, Dodiya HB, Popovic J, Cuddy LK, Weigle IQ, Zhang X, Sadleir K, Sisodia SS, Vassar R. The gut microbiome regulates astrocyte reaction to Abeta amyloidosis through microglial dependent and independent mechanisms. Mol Neurodegener. 2023;18(1):45. doi:10.1186/s13024-023-00635-2.
   PubMed Web of Science ®Google Scholar
• Li X, Li Y, Jin Y, Zhang Y, Wu J, Xu Z, Huang Y, Cai L, Gao S, Liu T. et al. Transcriptional and epigenetic decoding of the microglial aging process. Nat Aging. 2023;3(10):1288–1311. doi:10.1038/s43587-023-00479-x.
   PubMedGoogle Scholar
• Mone Y, Earl JP, Krol JE, Ahmed A, Sen B, Ehrlich GD, Lapides JR. Evidence supportive of a bacterial component in the etiology for Alzheimer’s disease and for a temporal-spatial development of a pathogenic microbiome in the brain. Front Cell Infect Microbiol. 2023;13:1123228. doi:10.3389/fcimb.2023.1123228.
   PubMed Web of Science ®Google Scholar
• Regen T, Isaac S, Amorim A, Núñez NG, Hauptmann J, Shanmugavadivu A, Klein M, Sankowski R, Mufazalov IA, Yogev N. et al. IL-17 controls central nervous system autoimmunity through the intestinal microbiome. Sci Immunol. 2021;6(56):eaaz6563. doi:10.1126/sciimmunol.aaz6563.
   PubMed Web of Science ®Google Scholar
• Lee JS, Wang RX, Alexeev EE, Colgan SP. Intestinal Inflammation as a dysbiosis of energy procurement: New Insights into an old topic. Gut Microbes. 2021;13(1):1–20. doi:10.1080/19490976.2021.1880241.
   Web of Science ®Google Scholar
• Madry C, Kyrargyri V, Arancibia-Carcamo IL, Jolivet R, Kohsaka S, Bryan RM, Attwell D. Microglial Ramification, surveillance, and interleukin-1beta release are regulated by the two-pore domain K(+) channel THIK-1. Neuron. 2018;97(2):299–312 e296. doi:10.1016/j.neuron.2017.12.002.
   PubMed Web of Science ®Google Scholar
• Zeng X, Li J, Shan W, Lai Z, Zuo Z. Gut microbiota of old mice worsens neurological outcome after brain ischemia via increased valeric acid and IL-17 in the blood. Microbiome. 2023;11(1):204. doi:10.1186/s40168-023-01648-1.
   PubMed Web of Science ®Google Scholar
• Li Y, Dong J, Xiao H, Zhang S, Wang B, Cui M, Fan S. Gut commensal derived-valeric acid protects against radiation injuries. Gut Microbes. 2020;11(4):789–806. doi:10.1080/19490976.2019.1709387.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM. et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388–405. doi:10.1016/S1474-4422(15)70016-5.
   PubMed Web of Science ®Google Scholar
• Michaud JP, Halle M, Lampron A, Theriault P, Prefontaine P, Filali M, Tribout-Jover P, Lanteigne AM, Jodoin R, Cluff C. et al. Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid a improves Alzheimer’s disease-related pathology. Proc Natl Acad Sci USA. 2013;110(5):1941–1946. doi:10.1073/pnas.1215165110.
   PubMed Web of Science ®Google Scholar
• Qin Y, Liu Y, Hao W, Decker Y, Tomic I, Menger MD, Liu C, Fassbender K. Stimulation of TLR4 attenuates alzheimer’s disease-related symptoms and pathology in tau-transgenic mice. J Immunol. 2016;197(8):3281–3292. doi:10.4049/jimmunol.1600873.
   PubMed Web of Science ®Google Scholar
• Scholtzova H, Chianchiano P, Pan J, Sun Y, Goni F, Mehta PD, Wisniewski T. Amyloid ß and Tau Alzheimer’s disease related pathology is reduced by toll-like receptor 9 stimulation. Acta Neuropathol Commun. 2014;2(1):101. doi:10.1186/PREACCEPT-2151623761356337.
   PubMedGoogle Scholar
• Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC, Mehta PD, Spinner DS, Wisniewski T. Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer’s disease-related pathology. J Neurosci. 2009;29(6):1846–1854. doi:10.1523/JNEUROSCI.5715-08.2009.
   PubMed Web of Science ®Google Scholar
• Patel AG, Nehete PN, Krivoshik SR, Pei X, Cho EL, Nehete BP, Ramani MD, Shao Y, Williams LE, Wisniewski T. et al. Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer’s disease pathology in aged squirrel monkeys. Brain. 2021;144(7):2146–2165. doi:10.1093/brain/awab129.
   PubMedGoogle Scholar
• Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR. et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest. 2005;115(11):3285–3290. doi:10.1172/JCI25247.
   PubMed Web of Science ®Google Scholar
• Storck SE, Meister S, Nahrath J, Meissner JN, Schubert N, Di Spiezio A, Baches S, Vandenbroucke RE, Bouter Y, Prikulis I. et al. Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier. J Clin Invest. 2016;126(1):123–136. doi:10.1172/JCI81108.
   PubMed Web of Science ®Google Scholar
• DeMattos RB, Cirrito JR, Parsadanian M, May PC, O’Dell MA, Taylor JW, Harmony JA, Aronow BJ, Bales KR, Paul SM. et al. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron. 2004;41(2):193–202. doi:10.1016/S0896-6273(03)00850-X.
   PubMed Web of Science ®Google Scholar
• He P, Zhong Z, Lindholm K, Berning L, Lee W, Lemere C, Staufenbiel M, Li R, Shen Y. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer’s mice. J Cell Biol. 2007;178(5):829–841. doi:10.1083/jcb.200705042.
   PubMed Web of Science ®Google Scholar
• Hur J-Y, Frost GR, Wu X, Crump C, Pan SJ, Wong E, Barros M, Li T, Nie P, Zhai Y. et al. The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease. Nature. 2020;586(7831):735–740. doi:10.1038/s41586-020-2681-2.
   PubMed Web of Science ®Google Scholar
• Mezo C, Dokalis N, Mossad O, Staszewski O, Neuber J, Yilmaz B, Schnepf D, de Aguero MG, Ganal-Vonarburg SC, Macpherson AJ. et al. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer’s disease. Acta Neuropathol Commun. 2020;8(1):119. doi:10.1186/s40478-020-00988-5.
   PubMed Web of Science ®Google Scholar
• Bramham CR, Worley PF, Moore MJ, Guzowski JF. The immediate early gene arc/arg3.1: regulation, mechanisms, and function. J Neurosci. 2008;28(46):11760–11767. doi:10.1523/JNEUROSCI.3864-08.2008.
   PubMed Web of Science ®Google Scholar
• Cerdo T, Ruiz-Rodriguez A, Acuna I, Torres-Espinola FJ, Menchen-Marquez S, Gamiz F, Gallo M, Jehmlich N, Haange SB, von Bergen M. et al. 1974. Infant gut microbiota contributes to cognitive performance in mice. Cell Host Microbe. 2023;31(12):1974–1988 e. doi:10.1016/j.chom.2023.11.004.
   PubMed Web of Science ®Google Scholar
• Lee J, Venna VR, Durgan DJ, Shi H, Hudobenko J, Putluri N, Petrosino J, Ld M, Bryan RM. Young versus aged microbiota transplants to germ-free mice: increased short-chain fatty acids and improved cognitive performance. Gut Microbes. 2020;12(1):1–14. doi:10.1080/19490976.2020.1814107.
   Web of Science ®Google Scholar
• Shakir L, Javeed A, Ashraf M, Riaz A. Metronidazole and the immune system. Pharmazie. 2011;66(6):393–398.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shen Y, Liufu N, Liu L, Li W, Shi Z, Zheng H, Mei X, Chen CY, Jiang Z. et al. Transmission of Alzheimer’s disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients. Mol Psychiatry. 2023;28(10):4421–4437. doi:10.1038/s41380-023-02216-7.
   PubMed Web of Science ®Google Scholar